
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Since its inception, Issar Pharma has been working on development of new peptide based drugs to treat different health problems. After six years of committed research, Issar Pharma invented and commercialised Indias first ever indigenously developed new peptide molecule, Decapeptide, for the novel treatment of Vitiligo. This product was released into the market in 2004 under the product name Melgain. Issar Pharma also invented and developed for the first time in the world its second peptide New Chemical Entity (NCE) which is first ever peptide based drug to treat burn wounds and microbial infection in India and world. This is...
Our mission is to address the unmet health care needs by developing new peptide based drugs and make them available in affordable cost to mankind.
Issar pharmaceuticals operates in the Pharmaceutical manufacturing industry.
Issar pharmaceuticals's revenue is 11m - 100m
Issar pharmaceuticals has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.